Moxeza is not available in generic form at this time. The earliest predictable date for the introduction for a generic version to be introduced is September 2014, when the next patent expires. The active ingredient, moxifloxacin, is sometimes referred to as the "generic name"; however, this is not the same thing as a generic version.
Can I Buy Generic Moxeza?Moxeza™ (moxifloxacin eye drops) is a prescription eye drop used to treat bacterial conjunctivitis, commonly called "pink eye." It belongs to a class of medications known as fluoroquinolones.
This product is similar to an earlier version of moxifloxacin eye drops sold under the name Vigamox®, with some important differences. For instance, Moxeza is used just twice daily (Vigamox is used three times daily), and Moxeza is approved for use in individuals as young as four months old (Vigamox is approved for individuals as young as one year old).
Moxeza is manufactured by Alcon Laboratories, Inc. It is currently under the protection of a patent that prevents any generic versions from being manufactured in the United States.
When Will a Generic Version Be Available?
The first patent for Moxeza expired in June 2012. Yet, no generics are available at this time. This suggests that at least one later-expiring patent is still protecting the drug from generic competition. The next patent for Moxeza is set to expire in September 2014. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for new Moxeza uses. Once the patent expires, there may be several companies that manufacture a generic Moxeza drug.